Dr. Ricardo Perdigão Henriques is a Harvard and MIT-educated scientist turned venture capitalist, now Managing Partner at Biovance Capital. He focuses on early-stage biotech investments across Europe, with a notable success being the investment in CellmAbs, which resulted in Portugals largest-ever biotech deal upon its sale to BioNTech. Colleagues describe him as a visionary leader with integrity.
Having developed his career in both the USA and Portugal, Ricardo is passionate about elevating the Portuguese biotech ecosystem. He actively works to attract international investors to the region. He also dedicates time to education, teaching a venture capital course to Masters students at the University of Coimbra, mentoring the next generation of innovators.
He orchestrated the largest biotech transaction in Portugals history with the sale of oncology startup CellmAbs to BioNTech.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.